The role of complement in the acquired immune response

Immunology

Volumn 100, Issue 1, 2000, Pages 4-12

  Nielsen, C H ^a,b   Fischer, E M ^b   Leslie, R G Q ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD19 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENT RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; AUTOIMMUNITY; B LYMPHOCYTE; CELL JUNCTION; DENDRITIC CELL; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; LYMPH FOLLICLE; MOUSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANTIBODY FORMATION; ANTIGEN PRESENTATION; B-LYMPHOCYTES; COMPLEMENT SYSTEM PROTEINS; DENDRITIC CELLS, FOLLICULAR; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION;

EID: 0034105631     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00009.x     Document Type: Review

References (108)

1. 1. PEPYS M.B. (1974) Role of complement in induction of antibody production in vivo. Effect of cobra venom factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med 140, 126.
2. 2. PEPYS M.B. (1976) Role of complement in the induction of immunological responses. Transplant Rev 32, 93.
3. 3. BÖTTGER E.C., HOFFMANN T., HADDING U. & BITTER-SUERMANN D. (1985) Influence of genetically inherited complement deficiencies on the humoral response in guinea pigs. J Immunol 135, 4100.
4. 4. JACKSON C.G., OCHS H.D. & WEDGWOOD R.J. (1979) Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med 300, 1124.
5. 5. OCHS H.D., WEDGWOOD R.J., FRANK M.M., HELLER S.R. & HOSEA S.W. (1983) The role of complement in the induction of antibody responses. Clin Exp Immunol 53, 208.
6. 6. BÖTTGER E.C., METZGER S., BITTER-SUERMANN D., STEVENSON G., KLEINDIENST S. & BURGER R. (1986) Impaired humoral response in complement C3-deficient guinea pigs: absence of a secondary antibody response. Eur J Immunol 16, 1231.
7. 7. O'NEIL K.M., OCHS H.D., HELLER S.R., CORK L.C., MORRIS J.M. & WINKELSTEIN J.A. (1988) Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J Immunol 140, 1939.
8. 8. HEYMAN B., PILSTRÖM L. & SHULMAN M.J. (1988) Complement activation is required for the IgM-mediated enhancement of the antibody response. J Exp Med 167, 1999.
9. 9. SULLIVAN K.E. (1998) Complement deficiency and autoimmunity. Curr Opin Pediatr 10, 600.
10. 10. BÖTTGER E.C., HOFFMANN T., HADDING U. & BITTER-SUERMANN D. (1986) Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease. J Clin Invest 78, 689.
11. 11. PAPAMICHAIL M., GUTIERREZ C., EMBLING P., JOHNSON P., HOLBOROW E.J. & PEPYS M.B. (1975) Complement dependence of localisation of IgG in germinal centres. Scand J Immunol 4, 343.
12. 12. CHEN L.L., FRANK A.M., ADAMS J.C. & STEINMAN R.M. (1978) Distribution of horseradish peroxidase (HRP)-anti-HRP immune complexes in mouse spleen with special reference to follicular dendritic cells. J Cell Biol 79, 184.
13. 13. ENRIQUEZ-RINCON F. & KLAUS G.G. (1984) Follicular trapping of hapten erythrocyte-antibody complexes in mouse spleen. Immunology 52, 107.
14. 14. VAN DEN EERTWEGH A.J., LAMAN J.D., SCHELLEKENS M.M., BOERSMA W.J. & CLAASSEN E. (1992) Complement-mediated follicular localisation of T-independent type-2 antigens: the role of the marginal zone macrophages revisited. Eur J Immunol 22, 719.
15. 15. VAN DEN BERG T.K., DOPP E.A., DAHA M.R., KRAAL G. & DIJKSTRA C.D. (1992) Selective inhibition of immune complex trapping by follicular dendritic cells with monoclonal antibodies against rat C3. Eur J Immunol 22, 957.
16. 16. HEYMAN B., WIERSMA E.J. & KINOSHITA T. (1990) In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J Exp Med 172, 665.
17. 17. THYPHRONITIS G., KINOSHITA T., INOUE K. et al. (1991) Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J Immunol 147, 224.
18. 18. GUSTAVSSON S., KINOSHITA T. & HEYMAN B. (1995) Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J Immunol 154, 6524.
19. 19. HEBELL T., AHEARN J.M. & FEARON D.T. (1991) Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254, 102.
20. 20. DEMPSEY P.W., ALLISON M.E., AKKARAJU S., GOODNOW C.C. & FEARON D.T. (1996) C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348.
21. 21. AHEARN J.M., FISCHER M.B., CROIX D. et al. (1996) Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4, 251.
22. 22. MOLINA H., HOLERS V.M., LI B et al. (1996) Markedly impaired humoral response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci 93, 3357.
23. 23. FISCHER M.B., MA M., GOERG S. et al. (1996) Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157, 549.
24. 24. MOLINA H., KINOSHITA T., INOUE K., CAREL J.C. & HOLERS V.M. (1990) A molecular and immunochemical characterisation of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. J Immunol 145, 2974.
25. 25. CROIX D.A., AHEARN J.M., ROSENGARD A.M. et al. (1996) Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med 183, 1857.
26. 26. FANG Y., XU C., FU Y.X., HOLERS V.M. & MOLINA H. (1998) Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol 160, 5273.
27. 27. KAVERI S.V., LACROIX-DESMAZES S., MOUTHON L. & KAZATCHKINE M.D. (1998) Human natural autoantibodies: lessons from physiology and prospects for therapy. Immunologist 6, 227.
28. 28. CASALI P. & NOTKINS A.L. (1989) CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 10, 364.
29. 29. DIGHIERO G. (1997) Natural antibodies, tolerance, and autoimmunity. Ann N Y Acad Sci 815, 182.
30. H families. J Immunol 142, 4054.
31. 31. ARVIEUX J., YSSEL H. & COLOMB M.G. (1988) Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 65, 229.
32. 32. THORNTON B.P., VETVICKA V. & ROSS G.D. (1994) Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol 152, 1727.
33. 33. NIELSEN C.H., MATTHIESEN S., LYNG I. & LESLIE R.G.Q. (1997) The role of complement receptor 1 (CR1, CD35) in determining complex distribution between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes. Immunology 90, 129.
34. 34. BOACLE S.A., MORRIS M.A., HOLERS V.M. & KARP D.R. (1998) Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J Immunol 161, 6537.
35. 35. VILLIERS M.-B., VILLIERS C.L., JACQUIER-SARLIN M.R., GABERT F.M., JOURNET A.M. & COLOMB M.G. (1996) Covalent binding of C3b to tetanus toxin: influence on uptake/internalisation of antigen by antigen-specific and non-specific B cells. Immunology 89, 348.
36. 36. THORNTON B.P., VETVICKA V. & ROSS G.D. (1996) Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin Exp Immunol 104, 531.
37. 37. JACQUIER-SARLIN M.R., GABERT P.M., VILLIERS M.B. & COLOMB M.G. (1995) Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 84, 164.
38. 38. SERRA V.A., CRETIN F., PEPIN E., GABERT P.M. & MARCHE P.N. (1997) Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulphate-stable HLA-DR dimer production. Eur J Immunol 27, 2673.
39. 39. SANTORO L., DROUET C., REBOUL A., MACH J.P. & COLOMB M.G. (1994) Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells. Eur J Immunol 24, 1620.
40. 40. KOZONO Y., ABE R., KOZONO H., KELLY R.G., AZUMA T. & HOLERS V.M. (1998) Cross-linking CD21/CD35 or CD19 increases both B7 and B7 expression on murine splenic cells. J Immunol 160, 1565.
41. 41. CARTER R.H., SPYCHER M.O., NG, Y.C., HOFFMAN R. & FEARON D.T. (1988) Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol 141, 457.
42. 42. FINGEROTH J.D., HEATH M.E. & AMBROSINO D.M. (1989) Proliferation of resting B cells is modulated by CR2 and CR1. Immunol Lett 21, 291.
43. 43. CARTER R.H. & FEARON D.T. (1989) Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM. J Immunol 143, 1755.
44. 44. TSOKOS G.C., LAMBRIS J.D., FINKELMAN F.D., ANASTASSIOU E.D. & JUNE C.H. (1990) Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration. J Immunol 144, 1640.
45. 45. MOORE M.D., COOPER N.R., TACK B.F. & NEMEROW G.R. (1987) Molecular cloning of the cDNA encoding the Epstein Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Nat Acad Sci 84, 9194.
46. 46. FINGEROTH J.D., BENEDICT M.A., LEVY D.N. & STROMINGER J.L. (1989) Identification of murine complement receptor type 2. Proc Natl Acad Sci USA 86, 242.
47. 47. MATSUMOTO A.K., KOPICKY-BURD J., CARTER R.H., TUVESON D.A., TEDDER T.F. & FEARON D.T. (1991) Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J Exp Med 173, 55.
48. 48. BRADBURY L.E., KANSAS G.S., LEVY S., EVANS R.L. & TEDDER T.F. (1992) The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149, 2841.
49. 49. CARTER R.H. & FEARON D.T. (1992) CD19: lowering the threshold for antigen stimulation of B lymphocytes. Science 256, 105.
50. 50. MONGINI P.K., VILENSKY M.A., HlGHET P.F. & INMAN J.K. (1997) The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2). J Immunol 159, 3782.
51. 51. CAMPBELL K.S. (1999) Signal transduction from the B cell antigen-receptor. Curr Opin Immunol 11, 256.
52. 52. VAN NOESEL C.J., LANKESTER A.C., VAN SCHUNDEL G.M.W. & VAN LIER R.A.W. (1993) The CR2/CD19 complex on human B cells contains the Src-family kinase Lyn. Int Immunol 5, 699.
53. 53. FUJIMOTO M., POE J.C., JANSEN P.J., SATO S. & TEDDER T.F. (1999) CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J Immunol 162, 7088.
54. 54. CARTER R.H., DOODY G.M., BOLEN J.B. & FEARON D.T. (1997) Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex. J Immunol 158, 3062.
55. 55. LI X., SANDOVAL D., FREEBERG L. & CARTER R.H. (1997) Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig. J Immunol 158, 5649.
56. 56. TUVESON D.A., CARTER R.H., SOLTOFF S.P. & FEARON D.T. (1993) CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260, 986.
57. 57. MATSUMOTO A.K., MARTIN D.R., CARTER R.H., KLICKSTEIN L.B., AHEARN J.M. & FEARON D.T. (1993) Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J Exp Med 178, 1407.
58. 58. BAREL M., BALBO M., GAUFFRE A. & FRADE R. (1995) Binding sites of the Epstein Barr virus and C3d receptor (CR2, CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium-binding protein and the nuclear p120 ribonucleoprotein. Mol Immunol 32, 389.
59. 59. BOUILLIE S., BAREL M. & FRADE R. (1999) Signalling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway. J Immunol 162, 136.
60. 60. MUTA T., KUROSAKI T., MISULOVIN Z., SANCHEZ M., NUSSENZWEIG M.C. & RAVETCH J.V. (1994) A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature 368, 70.
61. 61. ONO M., BOLLAND S., TEMPST P. & RAVETCH J.V. (1996) Role of inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(γ)RIIB. Nature 383, 263.
62. 62. SáRMAY G., KONCZ G., PECHT I. & GERGELY J. (1997) Fcγ receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cells. Immunol Lett 57, 159.
63. 63. DUSTIN L.B., PLAS D.R., WONG J. et al. (1999) Expression of dominant-negative Src-homology domain 2-containing protein tyrosine kinase activity and B cell activation. J Immunol 162, 2717.
64. 64. TRIDANDAPANI S., PHEE H., SHIVAKUMAR L., KELLEY T.W. & COGGESHALL K.M. (1998) Role of SHIP in FcγRIIb-mediated inhibition of Ras activation in B cells. Mol Immunol 35, 1135.
65. 65. KONCZ G., PECHT I., GERGELY J. & SÁRMAY G. (1999) Fcγ receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase. Eur J Immunol 29, 1980.
66. 2+ mobilisation in FcγR-transfected human cells. Int Immunol 10, 141.
67. 67. REYNES M., AUBERT J.P., COHEN J.H. et al. (1985) Human follicular dendritic cells express CR1, CR2 and CR3 complement receptor antigens. J Immunol 135, 2687.
68. 68. YOSHIDA K., VAN DEN BERG T.K. & DIJKSTRA C.D. (1993) Two functionally different dendritic cells in secondary lymphoid follicles of mouse spleen, as revealed by CR1/2 and FcγRII-mediated immune complex trapping. Immunology 80, 34.
69. 69. VORA K.A., RAVETCH J.V. & MANSER T. (1997) Amplified follicular immune complex deposition in mice lacking the Fc receptor γ-chain does not alter maturation of the B cell response. J Immunol 159, 2116.
70. 70. LIU Y.J., JOSHUA D.E., WILLIAMS G.T., SMITH C.A., GORDON J. & MACLENNAN I.C. (1989) Mechanism of antigen-driven selection in germinal centres. Nature 342, 929.
71. 71. LINDHOUT E., MEVISSEN M.L., KWEKKEBOOM J., TAGER J.M. & DE GROOT C. (1993) Direct evidence that human follicular dendritic cells (FDC) rescue germinal centre B cells from death by apoptosis. Clin Exp Immunol 91, 330.
72. 72. NIE X., BASU S. & CERNY J. (1997) Immunization with immune complex alters the repertoire of antigen-reactive B cells in the germinal centres. Eur J Immunol 27, 3517.
73. 73. APEL M. & BEREK C. (1990) Somatic mutations in antibodies expressed by germinal centre B cells early after primary immunization. Int Immunol 2, 813.
74. 74. W.U.J., QIN D., BURTON G.F., SZAKAL A.K. & TEW J.G. (1996) Follicular dendritic cell-derived antigen and accessory activity in initiation of memory IgG responses in vitro. J Immunol 157, 3404.
75. 75. FU Y.X., MOLINA H., MATSUMOTO M., HUANG G., MIN J. & CHAPLIN D.D. (1997) Lymphotoxin-α (LTα) supports development of splenic follicular structure that is required for IgG responses. J Exp Med 185, 2111.
76. 76. KOZONO Y., DUKE R.C., SCHLEICHER M.S. & HOLERS V.M. (1995) Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis. Eur J Immunol 25, 1013.
77. 77. FISCHER M.B., GOERG S., SHEN L. et al. (1998) Dependence of germinal centre B cells on expression of CD21/CD35 for survival. Science 280, 582.
78. 78. KOOPMAN G., KEEHNEN R.M., LINDHOUT E., ZHOU D.F., DE GROOT C. & PALS ST. (1997) Germinal centre B cells rescued from apoptosis by CD40 ligation or attachment to follicular dendritic cells, but not by engagement of surface immunoglobulin or adhesion receptors, become resistant to CD95-induced apoptosis. Eur J Immunol 27, 1.
79. 79. MAEDA K., BURTON G.F., PADGETT D.A. et al. (1992) Murine follicular dendritic cells and low affinity receptors for IgE (FcεRII). J Immunol 148, 2340.
80. 80. KEREKES K., PRECHL J., BAJTAY Z., MIHALY J. & ERDEI A. (1998) A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int Immunol 10, 1923.
81. 81. MARQUART H.V., SVEHAG S.-E. & LESLIE R.G.Q. (1994) CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes. J Immunol 153, 307.
82. 82. YAMAKAWA M. & IMAI Y. (1992) Complement activation in the follicular light zones of human lymphoid tissues. Immunology 76, 378.
83. 83. QIN D., WU J., CARROLL M.C., BURTON G.F., SZAKAL A.K. & TEW J.G. (1998) Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. J Immunol 161, 4549.
84. 84. ERDEI A., BAJTAY Z., FáBRY Z. & GERGELY J. (1988) Appearance of acceptor-bound C3b on HLA-DR positive macrophages and on stimulated U937 cells; inhibition of Fcγ-receptors by the covalently fixed C3 fragments. Mol Immunol 25, 295.
85. 85. MAISON C.M., VILLIERS C.L. & COLOMB M.G. (1989) Secretion, cleavage and binding of complement component C3 by the human monocytic cell line, U937. Biochemistry 261, 407.
86. 86. MOLD C, NEMEROW G.R., BRADT B.M. & COOPER N.R. (1988) CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells. J Immunol 140, 1923.
87. 87. OLESEN E.H., JOHNSON A.A., DAMGAARD G. & LESLIE R.G.Q. (1998) The requirement of localised, CR2-mediated, alternative pathway (AP) activation of complement for covalent deposition of C3 fragments on normal B cells. Immunology 93, 177.
88. 88. SCHWENDINGER M.G., SPRUTH M., SCHOCH J., DIERICH M.P. & PRODINGER W.M. (1997) A novel mechanism of alternative pathway complement activation accounts for the deposition of C3-fragmenls on CR2-expressing homologous cells. J Immunol 158, 5455.
89. 89. LESLIE R.G.Q. (1999) The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2-(CD21-) mediated alternative pathway activation by B cells. Immunology 97, 371.
90. 90. FISCHER E., DRELIBRIAS C. & KAZATCHKINE M.D. (1991) Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146, 865.
91. 91. CUTLER A.J., BOTTO M., VAN ESSEN D. et al. (1998) T cell-dependent immune response in C1q-deficient mice: defective interferon γ production by antigen-specific T cells. J Exp Med 187, 1789.
92. 92. SNAPPER C.M. & PAUL W.E. (1987) Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236, 944.
93. 93. SNAPPER C.M., MCINTYRE T.M., MANDLER R. et al. (1992) Induction of IgG3 secretion by interferon γ: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med 175, 1367.
94. 94. WALPORT M.J., DAVIES K.A., MORLEY B.J. & BOTTO M. (1997) Complement deficiency and autoimmunity. Ann N Y Acad Sci 815, 267.
95. 95. FRANK M.M. (1995) Animal models for complement deficiencies. J Clin Immunol 15, 113S.
96. 96. WINKELSTEIN J.A., CORK L.C., GRIFFIN D.E., GRIFFIN J.W., ADAMS R.J. & PRICE D.L. (1981) Genetically determined deficiency of the third component of complement in the dog. Science 212, 1169.
97. 97. KORB L.C. & AHEARN J.M. (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158, 4525.
98. 98. ROSEN A., CASCIOLA-ROSEN L. & AHEARN J. (1995) Novel packages of viral self-antigens are generated during apoptosis. J Exp Med 181, 1157.
99. 99. WALPORT M.J., DAVIES K.A. & BOTTO M. (1998) C1q and systemic lupus erythematosus. Immunobiology 199, 265.
100. 100. MARQUART H.V., SVENDSEN A., RASMUSSEN J.M. et al. (1995) Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 101, 60.
101. 101. TAKAHASHI K., KOZONO Y., WALDSCHMIDT T. et al. (1997) Mouse complement receptors type 1 (CR1; CD35) and type 2 (CR2; CD21): expression on normal B subpopulations and decreased levels during the development of autoimmunity in MRL/1pr mice. J Immunol 159, 1557.
102. 102. MURAKAMI M. & HONJO T. (1995) B-1 cells and autoimmunity. Ann N Y Acad Sci 764, 402.
103. 103. ENGEL P., ZHOU L.J., ORD D.C., SATO S., KOLLER B. & TEDDER T.F. (1995) Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3, 39.
104. 104. SATO S., ONO N., STEEBER D.A., PISETSKY D.S. & TEDDER T.F. (1996) CD19 regulates B lymphocyte signalling thresholds critical for the development of B-1 lineage cells and autoimmunity. J Immunol 157, 4371.
105. 105. CARROLL M.C. & PRODEUS A.P. (1998) Linkages of innate and adaptive immunity. Curr Opin Immunol 10, 36.
106. 106. INAOKI M., SATO B., WEINTRAUB B.C., GOODNOW C.C. & TEDDER T.F. (1997) CD19-regulated signalling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 186, 1923.
107. 107. PRODEUS A.P., GEORG S., SHEN L.M. et al. (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9, 721.
108. r protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci USA 81, 881.